Empirical Analysis of the Main Input and Output of Healthcare Reform in China from 2009 to 2013_Chinese Journal of Evidence-Based Medicine

Authors：

 DENGFeng ^1,3 , ZHOUZhong-liang ² ,  GAOJian-min ² , ZHOUZhi-ying ³ , YANGPei-rong ¹

1. Baoji Center for Disease Control and Prevention, Baoji 721006, China;
2. School of Public Policy and Administration, Xi'an Jiao Tong University, Xi'an 710049, China;
3. Health Science Center, Xi'an Jiao Tong University, Xi'an 710061, China;

Corresponding author：

GAOJian-min, Email: gaojm@mail.xjtu.edu.cn

Keywords：

China; Healthcare model; Healthcare reform; Transformation

DOI：

10.7507/1672-2531.20150150

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the main input and output of healthcare reform in China, and to provide references for improving the policies and measures of healthcare reform in China in future. Methods Data from the National Health Services Survey, and the China Statistical Yearbook etc. was collected to compare and analyze the allocation of health resources, health status of residents, health service utilization, and medical burden before and after healthcare reform. Results During the reform from 2009 to 2013, hospital health and technical personnel increased year by year. In 2013, the proportion of health and technical personnel in hospitals was up to 61.4% of the total national health technical personnel. In 2013, 65.19% of government expenditure on healthcare was used for disease treatment, and only 14.59% was used for disease prevention. Compared with the year of 2008, the two-week prevalence rate of residents increased by 5.2%, the chronic disease prevalence rate increased by 9% in 2013. Compared with the year of 2009, the annually diagnosed and treated patients increased 18.2 billion person-time, the annually discharged patients increased 59.65 million person-time in 2013. The individual residents paid 52.49% of total medical expenses. Conclusion Since the healthcare reform, China's central and local governments have imputed a large number of health resources into hospitals for "disease treatment". That partly improved the utilization of residents' health service, but the two-week prevalence rate and chronic disease prevalence rate are rapidly growing. There is still high burden of medical expenses for the residents. China's healthcare model should be changed from "treatment-centered" to "prevention-centered" in future.

Citation： DENGFeng, ZHOUZhong-liang, GAOJian-min, ZHOUZhi-ying, YANGPei-rong. Empirical Analysis of the Main Input and Output of Healthcare Reform in China from 2009 to 2013. Chinese Journal of Evidence-Based Medicine, 2015, 15(8): 887-891. doi: 10.7507/1672-2531.20150150 Copy

1.	Woolf SH. The need for perspective in evidence-based medicine. JAMA, 1999, 282:2358-2365.
2.	任苒. 国际健康目标与卫生改革的新导向——重视预防保健的作用. 医学与哲学(人文社会医学版), 2010, 31(4):5-8.
3.	雷海潮, 刘兴柱, 卞鹰, 等. 我国慢性病患病率的未来趋势研究.中国卫生经济, 1996, 10:18-19.
4.	雷海潮, 刘兴柱, 卞鹰, 等. 糖尿病、脑血管病、冠心病患病率的未来趋势研究. 中国卫生经济, 1996, 10:7-9.
5.	卫生部统计信息中心. 2008中国卫生服务调查研究. 中国协和医科大学出版社, 2009, 12.
6.	关于做好2014年国家基本公共卫生服务项目工作的通知. Available at:http://www.nhfpc.gov.cn/jws/zcwj/201409/acaeab089ac44d7a87d38393ccec4a78.shtml.
7.	徐玲, 孟群. 第五次国家卫生服务调查结果之二——卫生服务需要、需求和利用. 中国卫生信息管理杂志, 2014, 11(3):193-194.
8.	Ministry of Finance of the people's Republic of China. China's public expenditure statement in 2013. Available at:http://yss.mof.gov.cn/2013qgczjs/201407/t20140711_1111874.html.
9.	China Insurance Regulatory Commission. China insurance statistics report in 2013. Available at:http://www.circ.gov.cn/web/site0/tab5257/info3901864.htm.
10.	Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention:Health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet, 2007, 370 (9604):2044-2053.
11.	Lim SS. Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries:Health effects and costs. Lancet, 2007, 370(9604):2054-2062.
12.	Jamison, DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries. New York:Oxford University Press, 2006.
13.	吴锡桂, 顾东风, 武阳丰, 等. 首都钢铁公司人群心血管病24年干预效果评价. 中国预防医学杂志, 2003, 37 (2):93-97.
14.	Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study:A 20-year follow-up study. Lancet, 2008, 371(9626):1783-1789.
15.	Puska P. Successful prevention of NCDs:25 year experience with North Karelia Project in Finland. Public Health Medicine, 2002, 4(1):5-7.
16.	Patricio V, Marquez P, Lead Health Specialist, et al. Dying too young:Addressing premature mortality and ill health due to non-communicable diseases and injuries in the Russian Federation. Washington, DC:The World Bank, 2005.

1. Woolf SH. The need for perspective in evidence-based medicine. JAMA, 1999, 282:2358-2365.
2. 任苒. 国际健康目标与卫生改革的新导向——重视预防保健的作用. 医学与哲学(人文社会医学版), 2010, 31(4):5-8.
3. 雷海潮, 刘兴柱, 卞鹰, 等. 我国慢性病患病率的未来趋势研究.中国卫生经济, 1996, 10:18-19.
4. 雷海潮, 刘兴柱, 卞鹰, 等. 糖尿病、脑血管病、冠心病患病率的未来趋势研究. 中国卫生经济, 1996, 10:7-9.
5. 卫生部统计信息中心. 2008中国卫生服务调查研究. 中国协和医科大学出版社, 2009, 12.
6. 关于做好2014年国家基本公共卫生服务项目工作的通知. Available at:http://www.nhfpc.gov.cn/jws/zcwj/201409/acaeab089ac44d7a87d38393ccec4a78.shtml.
7. 徐玲, 孟群. 第五次国家卫生服务调查结果之二——卫生服务需要、需求和利用. 中国卫生信息管理杂志, 2014, 11(3):193-194.
8. Ministry of Finance of the people's Republic of China. China's public expenditure statement in 2013. Available at:http://yss.mof.gov.cn/2013qgczjs/201407/t20140711_1111874.html.
9. China Insurance Regulatory Commission. China insurance statistics report in 2013. Available at:http://www.circ.gov.cn/web/site0/tab5257/info3901864.htm.
10. Asaria P, Chisholm D, Mathers C, et al. Chronic disease prevention:Health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet, 2007, 370 (9604):2044-2053.
11. Lim SS. Gaziano TA, Gakidou E, et al. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries:Health effects and costs. Lancet, 2007, 370(9604):2054-2062.
12. Jamison, DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries. New York:Oxford University Press, 2006.
13. 吴锡桂, 顾东风, 武阳丰, 等. 首都钢铁公司人群心血管病24年干预效果评价. 中国预防医学杂志, 2003, 37 (2):93-97.
14. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study:A 20-year follow-up study. Lancet, 2008, 371(9626):1783-1789.
15. Puska P. Successful prevention of NCDs:25 year experience with North Karelia Project in Finland. Public Health Medicine, 2002, 4(1):5-7.
16. Patricio V, Marquez P, Lead Health Specialist, et al. Dying too young:Addressing premature mortality and ill health due to non-communicable diseases and injuries in the Russian Federation. Washington, DC:The World Bank, 2005.

Chinese Journal of Evidence-Based Medicine

Empirical Analysis of the Main Input and Output of Healthcare Reform in China from 2009 to 2013

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content